Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Following is an edited excerpt from one of the Rapid Responses generated by this article, which can be read in their entirety at http://bmj.com/cgi/eletters/326/7383/256 Editor
| The first 150 words of the full text of this article appear below. |
From BMJ USA 2003;April:211
Editor In 2000, the early breast cancer trials collaborative group
reported long-term follow-up of patients treated by radiotherapy for
breast cancer and showed an increased mortality rate from
cardiovascular events (
Lancet 2000;355:1757-1770[CrossRef][ISI][Medline]). This is
widely known and accepted in oncology. However, it is related to what
would now be considered as poor radiotherapy techniques and poor
fractionation schedules. Indeed, more recent reports have shown not
only the established two-thirds reduction in local recurrence when
radiotherapy is used after mastectomy, but also an overall survival
benefit of around 9%. In addition, Overgaard has shown no excess
cardiac deaths in patients followed for over 10 years [see references
on bmj.com]. As a result, many patients who have had
Norfolk and Norwich University Hospital, Norfolk, UK adrian.harnett@nnuh.nhs.uk